Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Wall Street
Price Targets
AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AUPH
is 17.05 USD
with a low forecast of 13.13 USD and a high forecast of 22.05 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AUPH's stock price target?
Price Target
17.05
USD
According to Wall Street analysts, the average 1-year price target for
AUPH
is 17.05 USD
with a low forecast of 13.13 USD and a high forecast of 22.05 USD.
What is Aurinia Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
18%
For the last 13 years the
compound annual growth rate for
Aurinia Pharmaceuticals Inc's revenue is
52%.
The projected
CAGR
for the next 4 years is
18%.
What is Aurinia Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
80%
The
compound annual growth rate
of Aurinia Pharmaceuticals Inc's operating income for the next 4 years is
80%.
What is Aurinia Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
133%
The
compound annual growth rate
of Aurinia Pharmaceuticals Inc's net income for the next 4 years is
133%.
